ArticleOncotarget2015

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.

Sripathi M Sureban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.